Ohalo Genetics
PrivateLast Round
Series B
Feb 24, 2025
Est. Valuation
$240M
Total Funding Raised
$130M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ohalo Genetics operates in Healthcare & Life Sciences and is based in Aptos, California. Its latest recorded funding round was a Series B round in February 2025.
Ohalo Genetics is an agricultural biotechnology company that develops plant breeding technologies and crop varieties to improve yield, sustainability, and efficiency in global agriculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ohalo Genetics Comparables
Compare Ohalo Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pairwise | 79% | |
| Phytoform Labs | 73% | |
| Cibus, Inc. | 73% |
For institutional investors. Book with your work email.
Ohalo Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 24, 2025 | ||||
| Series A | Jan 25, 2024 | ||||
| VC Round | Sep 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ohalo Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valor Capital Group | Series A |
| S32 | Series A |
| The Production Board | Series B, VC Round, Seed, Series A |
| Craft Ventures | Series A, Series B |
| S2G Investments | Series B |
| Hedosophia | Series A |
| Valor Equity Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 39% MoM.
- Jul 24, 2026
Grew 16% QoQ, from 105 to 122 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 18, 2026
Ohalo appoints Rob Dunlop as Vice President, Global Commercial in California on Aug 18th '26; he joins from Inari to lead agronomic and support systems for growers and manage channel partnerships for global market access.
- has_revenueAug 10, 2026
Ohalo records $8.4M in revenue in 2025.
For institutional investors. Book with your work email.
Ohalo Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ohalo Genetics's valuation, stock price, and market status.
Is Ohalo Genetics a public or private company?
Ohalo Genetics is a private company.
What is the current stock price of Ohalo Genetics?
Ohalo Genetics is a private company, so its shares have no public market price. Caplight tracks Ohalo Genetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ohalo Genetics worth (valuation)?
Ohalo Genetics's valuation is estimated at $240.0M based on funding round data.
Can I buy Ohalo Genetics stock?
Ohalo Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ohalo Genetics's last funding round?
Ohalo Genetics's most recent funding round was Series B on February 24, 2025.
Who are the main investors in Ohalo Genetics?
Key investors in Ohalo Genetics include The Production Board, Craft Ventures.
Will Ohalo Genetics IPO soon?
No public IPO plans have been announced for Ohalo Genetics.
How can I track Ohalo Genetics secondary market activity?
Caplight tracks bids, offers, and trades in Ohalo Genetics's shares on secondary markets.